首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Processing of Alzheimer beta/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation.
【2h】

Processing of Alzheimer beta/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation.

机译:阿尔茨海默氏症β/ A4淀粉样前体蛋白的加工:通过调节蛋白磷酸化的试剂进行调节。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The turnover and processing of the Alzheimer beta/A4 amyloid precursor protein (beta APP) has been studied in PC12 cells after treatment with agents that regulate protein phosphorylation. Phorbol 12,13-dibutyrate, an agent that stimulates protein kinase C, decreased the levels of mature beta APP and increased the levels of 15- and 19-kDa peptides. These peptides appeared to be COOH-terminal fragments of beta APP, which arose when phorbol 12,13-dibutyrate increased the rate of proteolytic processing of mature forms of beta APP. Okadaic acid, an inhibitor of protein phosphatases 1 and 2A, also led to decreased levels of mature beta APP and increased levels of the 15- and 19-kDa peptides. H-7, an inhibitor of protein kinase C and of several other protein kinases, apparently decreased the rate of proteolytic processing of mature beta APP. The sizes of the putative COOH-terminal fragments observed after treatment with either phorbol 12,13-dibutyrate or okadaic acid suggest that one or both may contain the entire beta/A4 region of beta APP and thus be amyloidogenic. Our results support the hypothesis that abnormal protein phosphorylation may play a role in the development of the cerebral amyloidosis that accompanies Alzheimer disease.
机译:在用调节蛋白质磷酸化的试剂处理后,已在PC12细胞中研究了阿尔茨海默氏症β/ A4淀粉样蛋白前体蛋白(βAPP)的更新和加工过程。 Phorbol 12,13-dibutyrate,一种刺激蛋白激酶C的药物,降低了成熟βAPP的水平,并增加了15-和19-kDa肽的水平。这些肽似乎是βAPP的COOH末端片段,当佛波醇12,13-二丁酸酯增加了βAPP的成熟形式的蛋白水解加工速率时出现。冈田酸,蛋白磷酸酶1和2A的抑制剂,还导致成熟的βAPP的水平降低,而15-和19-kDa肽水平升高。 H-7是蛋白激酶C和其他几种蛋白激酶的抑制剂,显然降低了成熟βAPP的蛋白水解过程。用佛波醇12,13-二丁酸酯或冈田酸处理后观察到的推定的COOH末端片段的大小表明,一个或两个都可能包含βAPP的整个beta / A4区,因此具有淀粉样变性。我们的研究结果支持以下假设:蛋白质异常磷酸化可能在阿尔茨海默氏症伴发的大脑淀粉样变性病的发展中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号